ArticleLeukemia2022

Cyclin-dependent kinase inhibitor fadraciclib (CYC065) depletes anti-apoptotic protein and synergizes with venetoclax in primary chronic lymphocytic leukemia cells.

Rong Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.